Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Search
Search
Search
SOLACI Congress
SOLACI & SBHCI 2026
Welcome to SOLACI & SBHCI 2026
Highlights
General Information
Authorities
SOLACI-SOCIME 2025 Certificates
Facebook
Instagram
Linkedin
Twitter
Youtube
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Home
CONGRESS
CONGRESS
SOLACI Congresses
SOLACI-SOCIME 2022
News
The Best of Main Arena
Live Cases
The Best Moments of the Congress
Day 3
Day 2
View Category
Day 2
STREAM trial: It is time to check out facilitated angioplasty?
It is not clear so far whether pre-hospital fibrinolysis with early angiography could provide a clinical outcome...
solaci
-
24 June, 2015
Learn More
Day 2
DKCRUSH-III: Crushing versus Culotte technique for left main coronary artery
Angioplasty of the unprotected distal left main coronary artery with 2 stents presents the less favorable results...
solaci
-
24 June, 2015
Learn More
Day 2
NEXT trial looked at a non-inferiority degradable polymer stent versus a second-generation permanent polymer stent.
Previous studies of non-inferiority (SORT-OUT III and V) compared the biodegradable polymer biolimus-eluting stent (BES) with permanent...
solaci
-
24 June, 2015
Learn More
Day 2
PRATO ACS: Rosuvastatin reduces the incidence of contrast nephropathy in patients with acute coronary syndrome who receive early invasive strategy
The aim of this study was to determine whether patients without ST-segment elevation acute coronary syndromes who...
solaci
-
24 June, 2015
Learn More
Day 1
TCT Session
Alan Wilson and Szeto Zajarias show that vascular complications of the trans-femoral path remain an important factor...
solaci
-
24 June, 2015
Learn More
Day 1
PREVAIL: LAA occlusion versus anticoagulation with warfarin to prevent stroke in patients with non-valvular atrial fibrillation.
An hour before the presentation of the PREVAIL study, the ACC announced the cancellation of the release...
solaci
-
24 June, 2015
Learn More
Day 1
THRIVE: Niacin/laropiprant extended release showed no significant cardiovascular benefit.
The THRIVE study, (also known as HPS2-THRIVE), was a multicenter clinical trial designed to test the hypothesis...
solaci
-
24 June, 2015
Learn More
SOLACI Session
How to prevent TAVI complications with current technology
Antonio Dager2013-05-21
solaci
-
24 June, 2015
Learn More